• Home
  • Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells.

Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells.

Author List
Chen WC, To MD, Westcott PMK, Delrosario R, Kim IJ, Philips M, Tran Q, Bollam SR, Goodarzi H, Bayani N, Mirzoeva O, Balmain A
Publication
Nature communications
Publication ID (Profile URL)
https://researcherprofiles.org/profile/212336971
Publication Year
2021
PubMed ID
34257283
Publication Title
Chen WC, To MD, Westcott PMK, Delrosario R, Kim IJ, Philips M, Tran Q, Bollam SR, Goodarzi H, Bayani N, Mirzoeva O, Balmain A. Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells. Nat Commun. 2021 07 13; 12(1):4288.